在线日韩日本国产亚洲丨少妇伦子伦情品无吗丨欧美性猛交xxxx免费看蜜桃丨精品人妻系列无码一区二区三区丨亚洲精品无码不卡在线播放

Your Good Partner in Biology Research

KLK4 Antibody

  • 中文名稱:
    KLK4兔多克隆抗體
  • 貨號(hào):
    CSB-PA211882
  • 規(guī)格:
    ¥1100
  • 圖片:
    • The image on the left is immunohistochemistry of paraffin-embedded Human cervical cancer tissue using CSB-PA211882(KLK4 Antibody) at dilution 1/15, on the right is treated with fusion protein. (Original magnification: ×200)
    • The image on the left is immunohistochemistry of paraffin-embedded Human thyroid cancer tissue using CSB-PA211882(KLK4 Antibody) at dilution 1/15, on the right is treated with fusion protein. (Original magnification: ×200)
  • 其他:

產(chǎn)品詳情

  • Uniprot No.:
  • 基因名:
  • 別名:
    7S nerve growth factor alpha chain antibody; AI2A1 antibody; Alpha-NGF antibody; Androgen-regulated message 1 antibody; ARM1 antibody; EC 3.4.21.- antibody; EMSP 1 antibody; EMSP antibody; EMSP1 antibody; Enamel Matrix Serine Protease 1 antibody; Enamel matrix serine proteinase 1 antibody; HK4 antibody; Kallikrein 1-related peptidase-like b4 antibody; Kallikrein 4 (prostase, enamel matrix, prostate) antibody; Kallikrein 4 antibody; Kallikrein antibody; Kallikrein L1 antibody; Kallikrein like protein 1 antibody; Kallikrein related-peptidase 4 (prostase, enamel matrix, prostate) antibody; Kallikrein-4 antibody; Kallikrein-like protein 1 antibody; Kallikrein-related peptidase 4 antibody; KLK 4 antibody; KLK L1 antibody; KLK-L1 antibody; KLK4 antibody; KLK4_HUMAN antibody; MGC116827 antibody; MGC116828 antibody; Prostase antibody; Protease Serine 17 antibody; PRSS 17 antibody; PRSS17 antibody; PSTS antibody; Serine protease 17 antibody
  • 宿主:
    Rabbit
  • 反應(yīng)種屬:
    Human
  • 免疫原:
    Fusion protein of Human KLK4
  • 免疫原種屬:
    Homo sapiens (Human)
  • 標(biāo)記方式:
    Non-conjugated
  • 抗體亞型:
    IgG
  • 純化方式:
    Antigen affinity purification
  • 濃度:
    It differs from different batches. Please contact us to confirm it.
  • 保存緩沖液:
    -20°C, pH7.4 PBS, 0.05% NaN3, 40% Glycerol
  • 產(chǎn)品提供形式:
    Liquid
  • 應(yīng)用范圍:
    ELISA,IHC
  • 推薦稀釋比:
    Application Recommended Dilution
    ELISA 1:2000-1:5000
    IHC 1:25-1:100
  • Protocols:
  • 儲(chǔ)存條件:
    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • 貨期:
    Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
  • 用途:
    For Research Use Only. Not for use in diagnostic or therapeutic procedures.

產(chǎn)品評(píng)價(jià)

靶點(diǎn)詳情

  • 功能:
    Has a major role in enamel formation. Required during the maturation stage of tooth development for clearance of enamel proteins and normal structural patterning of the crystalline matrix.
  • 基因功能參考文獻(xiàn):
    1. During the descriptive analysis, the variables ethnicity, biofilm, and gingivitis and the markers rs2242670 and rs2978642 were statistically significant. In the multivariate analysis, the marker rs2242670 and the variable biofilm maintained statistical significance. Genetic variations in the KLK4 gene may contribute to dental decay. PMID: 28445870
    2. Epithelial-derived KLK4 promotes tumour progression by actively promoting cancer-associated fibroblasts differentiation in the prostate stromal microenvironment. PMID: 28510269
    3. structural analysis of mechanism of KLK4 inhibition PMID: 27767076
    4. These findings prompt a new mechanistic model and line of enquiry into the role of KLK4 in enamel hardening and malformation. PMID: 29229389
    5. Results show that AMTN and KLK4 are not essential for biological processes outside of the dentition or during the secretory stage of amelogenesis. Both KLK4 and AMTN proved to be essential for the maturation of dental enamel, a process that requires the removal of extracellularmatrix proteins and the deposition of ions on the sides of enamel crystallites. PMID: 26620968
    6. The KLK4 protein is localized in the cytoplasm of tumor and stroma cells. PMID: 28755528
    7. KLK4 as a potential multifunctional regulator of prostate cancer progression. PMID: 27378148
    8. Low KLK4 expression is associated with lupus nephritis. PMID: 26546590
    9. KLK4 may contribute to the metastasis of OSCC through the PI3 K/AKT signaling pathway PMID: 28743213
    10. KLK4 acts as an oncogene in OSCC cells, and targeting KLK4 may be a promising method for OSCC therapy. PMID: 28150891
    11. Studied a 70-kb region surrounding KLK4 in East Asian population; found within combined unusual low levels of diversity, high frequency variants with significant levels of population differentiation. PMID: 26420451
    12. secreted into the extracellular microenvironment by neutrophils stimulated with bioactive mediators PMID: 25563717
    13. Novel homozygous mutations in the KLK4 (c.620_621delCT, p.Ser207Trpfs*38) were identified in amelogenesis imperfecta consanguinity. Mutant KLK4 was degraded intracellularly and became inactive. PMID: 26124219
    14. this study provides supportive evidence in favor of a prognostic value for KLK4 in OSCC and suggests that KLK4 could serve as a potential therapeutic target in patients with oral cancer. PMID: 25862839
    15. Human ephrin-B2 is poorly cleaved by KLK4 while the homologous mouse is not. PMID: 25724897
    16. miR-378 was predicted to target both KLK2 and KLK4 and downregulated levels detected in prostate cancer patients. PMID: 25153390
    17. The differential regulation of alternative transcripts (using KLK2, KLK3 and KLK4 as models) by androgens and anti-androgens as an indicator of prostate cancers, was investigated. PMID: 25153393
    18. KLK4 mRNA positivity could be regarded as a novel independent indicator of favorable prognosis for the disease-free survival of laryngeal squamous cell carcinoma patients. PMID: 24854539
    19. The variant rs1722561 of Kallikreins might reduce the risk of sporadic intracranial aneurysms among individuals of Chinese Han ethnicity. PMID: 24405067
    20. These results demonstrate that the activities of AR and mTOR pathways are maintained by KLK4, which may thus be a viable target for therapy PMID: 23798432
    21. Survival analysis demonstrated that KLK4 mRNA expression constitutes an unfavorable prognostic biomarker in colorectal adenocarcinoma, predicting poor disease-free survival (DFS), independently of the nodal status and tumor size. PMID: 23201139
    22. amelogenesis imperfecta-causing mutations were identified in three of the probands: 1) a novel single-nucleotide deletion in both KLK4 alleles (g.6930delG; c.245delG; p.Gly82Alafs*87) that shifted the reading frame. PMID: 23355523
    23. findings provide suggestive evidence of a role for genetic variation in the KLK4 locus in prostate cancer predisposition PMID: 22970239
    24. signal peptide induces cytotoxic T cell responses in healthy donors and prostate cancer patients PMID: 21874303
    25. Complex gene expression at the KLK4 locus that might be a hallmark of cis sense-antisense chimeric transcription in prostate cancer cells. PMID: 20406994
    26. KLK4 is upregulated in early-stage but not late-stage prostate cancer. PMID: 20180634
    27. KLK4 signaling via PAR1 may represent a novel pathway in colon tumorigenesis. PMID: 20056842
    28. Kallikrein 4 overexpression is associated with endometrial carcinoma. PMID: 20009893
    29. Prostate cancer cells exhibit a novel double-paracrine mechanism whereby cancer epithelium produces KLK4 to activate PAR-1 in the surrounding stroma, in-turn releasing cytokines that stimulate cancer cells to proliferate & increase production of KLKs. PMID: 19795418
    30. The demonstration that KLK4-specific CD4 T cells exist in the peripheral circulation of normal male donors supports the use of KLK4 in whole gene-, protein-, or peptide-based vaccine strategies against prostate cancer. PMID: 12077288
    31. KLK4 has a unique structure and function compared with other members of the KLK family and may have a role in the biology and characterization of prostate cancer. PMID: 15059887
    32. A novel human kallikrein mutation associated with a rare autosomal recessive form of amelogenesis imperfecta. PMID: 15235027
    33. Human kallikrein 4, in particular, and prostate specific antigen, have a functional role in the progression of prostate cancer through their promotion of tumour cell migration. PMID: 16172196
    34. There are two major isoforms of hK4 (KLK4-254/hK4-254 and KLK4-205/hK4-205) expressed in prostate cancer with different regulatory and expression profiles that imply both secreted and novel nuclear roles. PMID: 16322328
    35. Here we demonstrate uPAR is a target for tissue kallikrein 4[hK4], cleaved in the D1-D2 linker and D3 domain. hK4 may modulate tumor-associated uPA/uPAR activity by activating the pro-enzyme form of uPA or cleaving the cell surface-associated uPA receptor PMID: 16497155
    36. Design of serpin fragments as highly specific inhibitors of human kallikrein 14. PMID: 16704423
    37. an investigation of its enzymatic properties regarding substrate preference, degradation of extracellular matrix proteins, and its inhibition by various inhibitors PMID: 16800736
    38. hK4 expression and interaction with both tumor cells and osteoblasts suggests a role for hK4 in prostate cancer bone metastasis PMID: 17221837
    39. KLK4 protein is significantly overexpressed in malignant prostate compared with normal prostate. KLK4 expression is predominantly in the nucleus of basal cells in the prostate epithelium in keeping with its distribution in prostate cancer cells in vitro. PMID: 17545602
    40. KLK4 and KLK5 activate pro-HGFA. PMID: 18221492
    41. These data provide insight into KLK4-mediated cell signaling and suggest that signals induced by this enzyme via protease-activated receptors may be important in prostate cancer. PMID: 18308730
    42. Recombinant hK4 activates ERK1/2 signaling of prostate cancer cell lines, which express both PAR1 and PAR2. PMID: 18567807
    43. KLK4 may be associated with the development and progression of breast cancer and suggest its potential use in breast cancer monitoring. PMID: 18687310
    44. KLK4 gene expression may be used as a new potential biomarker in breast cancer. PMID: 19190825
    45. In a family with a hypomaturation-type enamel defect, mutational and haplotype analyses revealed no mutations in the KLK4 gene. PMID: 19966041

    顯示更多

    收起更多

  • 相關(guān)疾病:
    Amelogenesis imperfecta, hypomaturation type, 2A1 (AI2A1)
  • 亞細(xì)胞定位:
    Secreted.
  • 蛋白家族:
    Peptidase S1 family, Kallikrein subfamily
  • 組織特異性:
    Expressed in prostate.
  • 數(shù)據(jù)庫鏈接:

    HGNC: 6365

    OMIM: 204700

    KEGG: hsa:9622

    STRING: 9606.ENSP00000326159

    UniGene: Hs.218366



主站蜘蛛池模板: 国产午夜永久福利视频在线观看 | 色婷婷日日躁夜夜躁| 久久国产主播福利在线| av毛片无码中文字幕不卡| 国产裸体歌舞一区二区| 久久不见久久见免费影院www | 日本少妇浓毛bbwbbwbbw| 久久久久久久久久久综合日本| 久久婷婷五月国产色综合| 亚洲欧美一区二区三区| 奇米影视7777狠狠狠狠色| 国产亚洲综合区成人国产系列| 国产欧美久久一区二区| 又爽又黄无遮拦成人网站| 欧美日韩人成视频在线播放| 国产精品扒开腿做爽爽爽a片唱戏 久久99国产精品久久99 | 东京热大乱系列无码| 中字幕视频在线永久在线观看免费| 狠狠色噜噜狠狠狠狠97首创麻豆| 真人做人60分钟啪啪免费看| 日韩亚洲国产中文永久| 成人h动漫精品一区二区无码 | 黑色丝袜无码中中文字幕| 日本又黄又爽gif动态图| 人人爽人人爽人人爽| 国产精品免费精品自在线观看| 无遮挡呻吟娇喘视频免费播放| 内谢少妇xxxxx8老少交| 免费拍拍拍网站| 午夜理论片yy44880影院| 国产亚洲香蕉线播放αv38| 无码日韩精品一区二区三区免费| 午夜福利理论片在线观看播放| 久久成人国产精品免费| 无码午夜人妻一区二区不卡视频| 日本不卡一区| 无码人妻视频一区二区三区| 2018高清日本一道国产-在| 狠狠躁18三区二区一区| 日本特黄特色特爽大片| 精品av中文字幕在线毛片|